Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Novartis chief continues cost-cutting drive
Fierce Pharma
Mon, 04/4/11 - 11:40 am
Novartis
Joe Jimenez
Pharma CEOs
layoffs
Analysis Flags Fears Over Avastin
WSJ Online
Mon, 04/4/11 - 09:04 am
Avastin
Lucentis
Roche
Novartis
off-label
Dividend Sector Review: Pharmaceuticals
Motley Fool
Thu, 03/31/11 - 10:15 pm
dividends
Eli Lilly
GSK
AstraZeneca
Roche
Merck
Novartis
Abbott Laboratories
Pfizer
JNJ
Merck, Novartis Blood Cancer Drugs May Shrink Child Tumors, Study Finds
Bloomberg
Wed, 03/30/11 - 12:44 pm
Novartis
Merck
HDAC inhibitors
LBH589
Zolinza
Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom
In-Pharm
Wed, 03/30/11 - 11:41 am
Roche
M&A
Novartis
Novartis, The iPad & 35,000 More Visits To Docs
Pharmalot
Tue, 03/29/11 - 08:34 am
Novartis
drug reps
Joe Jimenez
iPad
Novartis invests in Chinese vaccine maker
In-Pharmatechnologist
Mon, 03/28/11 - 09:52 am
China
Novartis
vaccines
Zhejiang Tianyuan Bio-Pharmaceutical
Top 5 Pharmaceuticals Paying Excellent Dividends
Seeking Alpha
Sun, 03/27/11 - 12:10 pm
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Novartis
Pfizer
Sanofi Profiles Zalicus Drug Today, a Positive Sign for Investors
Seeking Alpha
Thu, 03/24/11 - 09:22 am
Sanofi
Zalicus
Amgen
Novartis
ophthalmology
Prednisporin
What Biotech Wants From Big Pharma Partners: Survey Says!?
InVivo
Wed, 03/23/11 - 10:29 am
Big Pharma
biotech
Roche
Merck
GSK
Novartis
Pfizer
Eli Lilly
Novartis must wait longer for FDA lung drug decision
Reuters
Wed, 03/23/11 - 09:38 am
FDA
COPD
Novartis
QAB149
Failure of Sanofi, Merck Animal-Health Merger May Trigger Deals
Bloomberg
Tue, 03/22/11 - 10:12 pm
animal health
Merck
Sanofi
M&A
Novartis
Bayer
Pharmas in the Doghouse
Motley Fool
Tue, 03/22/11 - 10:06 pm
Merck
Sanofi
Pfizer
Genzyme
Novartis
Eli Lilly
JNJ
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Bloomberg
Tue, 03/22/11 - 11:07 am
Novartis
Gilenya
MS
multiple sclerosis
Teva Pharmaceuticals
Biogen Idec
Roche
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
Novartis gets EU approval for oral MS drug
Yahoo/AP
Mon, 03/21/11 - 11:19 am
Europe
MS
Novartis
multiple sclerosis
Meet the Cash Kings of Pharma
Motley Fool
Thu, 03/17/11 - 06:20 pm
Novartis
Sanofi
Bristol-Myers Squibb
FDA To Novartis: Ciba Vision Needs An Eye Exam
Pharmalot
Wed, 03/16/11 - 10:51 am
FDA
Novartis
CIBA Vision
Novartis maps out a blockbuster future for INC424
Fierce Biotech
Wed, 03/16/11 - 09:21 am
Novartis
INC424
Incyte
JAK inhibitors
ruxolitinib
myelofibrosis
Extending the Competition in Parkinson's Disease
Motley Fool
Wed, 03/16/11 - 09:17 am
Parkinson's Disease
Impax
Merck
Novartis
Pfizer
GSK
Pages
« first
‹ previous
…
135
136
137
138
139
140
141
142
143
…
next ›
last »